Camlin Fine Sciences Limited has informed the Exchange about change in Management

Cfo ResignedKmp ResignedManagement Changes View source PDF Explain this filing

CAMLINFINE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+7.2%Reaction day

₹121.50

prior close

₹120.99

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.0%+7.2% vs market

Specialty Chemicals peers, median of 92sector-0.5%+7.7% vs sector

On the reaction day the stock moved 7.2 pts more than Nifty Microcap 250 and 7.7 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

+3.9

15m

+4.2

30m

+6.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+7.2-0.0+7.2-0.5+7.7

Next day

+0.8-0.7+1.5-1.4+2.3

-2.9-1.8-1.1-2.5-0.3

-2.1-0.7-1.4-1.6-0.4

-3.6-0.5-3.1-2.1-1.4

-1.2+0.4-1.6-2.0+0.7

+4.7-1.6+6.3-3.4+8.2

15d

+12.8+4.6+8.1-1.1+13.8

+6.9+4.6+2.4-1.3+8.2

+5.2+6.1-0.9+2.8+2.4

-15.2+10.8-26.0+4.6-19.8

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 92Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Camlin Fine Sciences Limited held a Board Meeting on May 26, 2026 approving audited financial results for Q4 and FY ended March 31, 2026. Standalone revenue from operations was Rs 18,351.65 lakh for Q4 and Rs 83,791.82 lakh for FY2026 (down from Rs 88,649.13 lakh in FY2025). The company reported a standalone loss before tax of Rs 5,409.22 lakh for FY2026. The auditors Kalyaniwalla & Mistry LLP issued unmodified opinions. Key management changes include appointment of Mr. Pankaj Pandey as new CFO effective August 18, 2026, with Mr. Santosh Parab ceasing to hold CFO role and being re-designated as President – Strategy and Global CFO. The 33rd AGM is scheduled for August 11, 2026.

Likely market impact

The CFO transition represents a key management change. The company continues to face financial headwinds with declining standalone revenue and significant losses. However, the CFO transition appears to be an internal restructuring rather than a distress-related exit, as Mr. Parab remains with the company in a new role.